ALLOCYTE PHARMACEUTICALS AG has a total of 13 patent applications. Its first patent ever was published in 2015. It filed its patents most often in Singapore, United States and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are NUEVAS ALTERNATIVAS NATURALES S A P I DE C V, RMW CHO GROUP LTD and MYMD PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Singapore | 2 | |
#2 | United States | 2 | |
#3 | Australia | 1 | |
#4 | Brazil | 1 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | EPO (European Patent Office) | 1 | |
#8 | Israel | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Mexico | 1 | |
#11 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Climate change adaptation technologies | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Huerzeler Marianne | 10 |
#2 | Kelly Terence | 10 |
#3 | Breitenstein Werner | 10 |
#4 | Schneider Gisbert | 10 |
#5 | Mancuso Riccardo | 10 |
#6 | Weitz-Schmidt Gabriele | 9 |
#7 | Werner Breitenstein | 2 |
#8 | Terence Kelly | 2 |
#9 | Gisbert Schneider | 2 |
#10 | Gabriele Weitz-Schmidt | 2 |
Publication | Filing date | Title |
---|---|---|
US2017121284A1 | Small molecule LFA-1 inhibitors |